BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 26405107)

  • 1. Novel GM1 ganglioside-like peptide mimics prevent the association of cholera toxin to human intestinal epithelial cells in vitro.
    Yu RK; Usuki S; Itokazu Y; Wu HC
    Glycobiology; 2016 Jan; 26(1):63-73. PubMed ID: 26405107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholera toxin B-mediated targeting of lipid vesicles containing ganglioside GM1 to mucosal epithelial cells.
    Lian T; Ho RJ
    Pharm Res; 1997 Oct; 14(10):1309-15. PubMed ID: 9358541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial-associated cholera toxin and GM1 binding are required for transcytosis of classical biotype Vibrio cholerae through an in vitro M cell model system.
    Blanco LP; DiRita VJ
    Cell Microbiol; 2006 Jun; 8(6):982-98. PubMed ID: 16681839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modifications of cholera toxin subunit B binding to human large intestinal epithelium. An immunohistochemical study.
    Kirkeby S; Lynge Pedersen AM
    Microb Pathog; 2018 Nov; 124():332-336. PubMed ID: 30145256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational changes in cholera toxin B subunit-ganglioside GM1 complexes are elicited by environmental pH and evoke changes in membrane structure.
    McCann JA; Mertz JA; Czworkowski J; Picking WD
    Biochemistry; 1997 Jul; 36(30):9169-78. PubMed ID: 9230049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence analysis of galactose, lactose, and fucose interaction with the cholera toxin B subunit.
    Mertz JA; McCann JA; Picking WD
    Biochem Biophys Res Commun; 1996 Sep; 226(1):140-4. PubMed ID: 8806604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide.
    Merritt EA; Sarfaty S; van den Akker F; L'Hoir C; Martial JA; Hol WG
    Protein Sci; 1994 Feb; 3(2):166-75. PubMed ID: 8003954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholera toxin binds to lipid rafts but has a limited specificity for ganglioside GM1.
    Blank N; Schiller M; Krienke S; Wabnitz G; Ho AD; Lorenz HM
    Immunol Cell Biol; 2007 Jul; 85(5):378-82. PubMed ID: 17325693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding Cooperativity Matters: A GM1-Like Ganglioside-Cholera Toxin B Subunit Binding Study Using a Nanocube-Based Lipid Bilayer Array.
    Worstell NC; Krishnan P; Weatherston JD; Wu HJ
    PLoS One; 2016; 11(4):e0153265. PubMed ID: 27070150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholera toxin B: one subunit with many pharmaceutical applications.
    Baldauf KJ; Royal JM; Hamorsky KT; Matoba N
    Toxins (Basel); 2015 Mar; 7(3):974-96. PubMed ID: 25802972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fucosylation and protein glycosylation create functional receptors for cholera toxin.
    Wands AM; Fujita A; McCombs JE; Cervin J; Dedic B; Rodriguez AC; Nischan N; Bond MR; Mettlen M; Trudgian DC; Lemoff A; Quiding-Järbrink M; Gustavsson B; Steentoft C; Clausen H; Mirzaei H; Teneberg S; Yrlid U; Kohler JJ
    Elife; 2015 Oct; 4():e09545. PubMed ID: 26512888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Picomolar inhibition of cholera toxin by a pentavalent ganglioside GM1os-calix[5]arene.
    Garcia-Hartjes J; Bernardi S; Weijers CA; Wennekes T; Gilbert M; Sansone F; Casnati A; Zuilhof H
    Org Biomol Chem; 2013 Jul; 11(26):4340-9. PubMed ID: 23689250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine lactoferrin decreases cholera-toxin-induced intestinal fluid accumulation in mice by ganglioside interaction.
    Rivera FP; Medina AM; Bezada S; Valencia R; Bernal M; Meza R; Maves RC; Ochoa TJ
    PLoS One; 2013; 8(4):e59253. PubMed ID: 23580005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hetero-multivalent binding of cholera toxin subunit B with glycolipid mixtures.
    Krishnan P; Singla A; Lee CA; Weatherston JD; Worstell NC; Wu HJ
    Colloids Surf B Biointerfaces; 2017 Dec; 160():281-288. PubMed ID: 28946063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for TLR4 and FcRγ-CARD9 activation by cholera toxin B subunit and its direct bindings to TREM2 and LMIR5 receptors.
    Phongsisay V; Iizasa E; Hara H; Yoshida H
    Mol Immunol; 2015 Aug; 66(2):463-71. PubMed ID: 26021803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of cholera toxin and GM1 ganglioside in the early endosome of Niemann-Pick C1-deficient cells.
    Sugimoto Y; Ninomiya H; Ohsaki Y; Higaki K; Davies JP; Ioannou YA; Ohno K
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12391-6. PubMed ID: 11675488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholera Toxin Encapsulated within Several
    Rasti ES; Brown AC
    Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 30959895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 'catch-and-release' receptor for the cholera toxin.
    Mahon CS; Wildsmith GC; Haksar D; de Poel E; Beekman JM; Pieters RJ; Webb ME; Turnbull WB
    Faraday Discuss; 2019 Oct; 219(0):112-127. PubMed ID: 31313796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganglioside GM1 levels are a determinant of the extent of caveolae/raft-dependent endocytosis of cholera toxin to the Golgi apparatus.
    Pang H; Le PU; Nabi IR
    J Cell Sci; 2004 Mar; 117(Pt 8):1421-30. PubMed ID: 14996913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation of HIV-envelope protein with lipid vesicles expressing ganglioside GM1 associated to cholera toxin B enhances mucosal immune responses.
    Lian T; Bui T; Ho RJ
    Vaccine; 1999 Nov; 18(7-8):604-11. PubMed ID: 10547418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.